Eli Lilly and Company
The Director of Generative Design & Optimization leads the scientific execution of Lilly's de novo biologics design capabilities, transforming foundation-model outputs into experimentally testable therapeutic candidates. This role involves leading a team of AI researchers and computational scientists to develop and scale integrated design pipelines for antibody and biotherapeutic discovery. The position requires expertise in AI/ML, protein engineering, and computational design to advance therapeutic molecule discovery.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Senior Scientist – Protein Design
AstraZeneca
Scientist - AI & ML for Protein and Antibody Engineering
Roche
Machine Learning Scientist, Data-Efficient Learning for Drug Discovery
Lila Sciences
Senior Machine Learning Scientist
Pfizer
Computational Theoretical Chemist I
1910
AI Computational Chemist
AstraZeneca